Atlas Trials

Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar Disorder

Clinical trial NCT01093937 · COMPLETED

Trial details

NCT number
NCT01093937
Sponsor
Centre for Addiction and Mental Health
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Nicotine Dependence
Start date
2009-11-01
Primary completion
2011-02-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.